Canada markets open in 1 hour 54 minutes

NLS Pharmaceutics Ltd. (NLSP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.1327-0.0003 (-0.23%)
At close: 04:00PM EDT
0.1382 +0.01 (+4.14%)
After hours: 06:34PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.75M
Enterprise Value 4.75M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.84
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.31

Trading Information

Stock Price History

Beta (5Y Monthly) -0.84
52-Week Change 3-91.25%
S&P500 52-Week Change 321.23%
52 Week High 31.5500
52 Week Low 30.1310
50-Day Moving Average 30.2909
200-Day Moving Average 30.5925

Share Statistics

Avg Vol (3 month) 3572.39k
Avg Vol (10 day) 3258.49k
Shares Outstanding 543.32M
Implied Shares Outstanding 636.45M
Float 819.89M
% Held by Insiders 131.54%
% Held by Institutions 123.84%
Shares Short (Mar 28, 2024) 4335.8k
Short Ratio (Mar 28, 2024) 40.24
Short % of Float (Mar 28, 2024) 41.33%
Short % of Shares Outstanding (Mar 28, 2024) 40.92%
Shares Short (prior month Feb 29, 2024) 461.82k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-414.25%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.33M
Net Income Avi to Common (ttm)-15.47M
Diluted EPS (ttm)-0.5000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.65M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.58
Book Value Per Share (mrq)-0.13

Cash Flow Statement

Operating Cash Flow (ttm)-13.51M
Levered Free Cash Flow (ttm)-7.95M